Zylem Biosciences

📍 Chicago, United States🗓 Founded 2018👥 4 employees💰 Last funded Aug 2019
Biotechnology Research🌐 zylembio.com
Website LinkedIn
Zylem Biosciences is a preclinical biotechnology startup, pioneering the development of targeted medicines by employing rational design inspired by nature. Our novel platform technology spans a deep pipeline of therapies applicable to diseases and conditions where lipid dysfunction plays a critical role, including cancer, skin disease, and eye disease. Visit our website to find out more.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2018
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Zylem Biosciences?
Zylem Biosciences has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Zylem Biosciences last raise funding?
The most recent investment in Zylem Biosciences recorded on gritt.io was in August 2019.
When was Zylem Biosciences founded?
Zylem Biosciences was founded in 2018.
What industry is Zylem Biosciences in?
Zylem Biosciences operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Zylem Biosciences based?
Zylem Biosciences is headquartered in Chicago, United States.